Reconciliation of alternative performance measures
In CHF million |
1.01.–31.03.2024 |
1.01.–31.03.2023 |
Change reported |
Change at constant exchange rates |
||||
---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 2,703 | 2,747 | –1.6% | –0.5% | ||||
Operating income before depreciation and amortisation (EBITDA) | ||||||||
EBITDA | 1,155 | 1,164 | –0.8% | –% | ||||
Legal proceedings in Switzerland | (24) | – | ||||||
Transaction costs for company acquisitions | 6 | – | ||||||
EBITDA adjusted | 1,137 | 1,164 | –2.3% | –1.5% | ||||
Capital expenditure | ||||||||
Capital expenditure in property, plant and equipment and intangible assets | 590 | 541 | 9.1% | 10.4% | ||||
Payments for indefeasible rights of use (IRU) | 4 | 4 | ||||||
Capital expenditure | 594 | 545 | 9.0% | 10.3% |
In CHF million |
1.01.–31.03.2024 |
1.01.–31.03.2023 |
Change reported |
|||
---|---|---|---|---|---|---|
Operating free cash flow | ||||||
Cash flow from operating activities | 881 | 845 | 36 | |||
Capital expenditure | (594) | (545) | (49) | |||
Depreciation of right-of-use assets | (65) | (66) | 1 | |||
Depreciation of indefeasible rights of use (IRU) | 5 | 5 | – | |||
Proceeds from finance lease receivables | (23) | (42) | 19 | |||
Change in deferred gain from the sale and leaseback of real estate | 1 | 1 | – | |||
Change in operating assets and liabilities | 198 | 228 | (30) | |||
Change in provisions | 27 | 15 | 12 | |||
Change in defined benefit obligations | 2 | 8 | (6) | |||
Gain on sale of property, plant and equipment | 2 | 1 | 1 | |||
Revenue from finance leases | 15 | 19 | (4) | |||
Interest received | (2) | (1) | (1) | |||
Interest payments for financial liabilities | 12 | 13 | (1) | |||
Income taxes paid | 30 | 65 | (35) | |||
Operating free cash flow | 489 | 546 | (57) | |||
Free cash flow | ||||||
Cash flow from operating activities | 881 | 845 | 36 | |||
Cash flow used in investing activities | (585) | (530) | (55) | |||
Repayment of lease liabilities | (96) | (98) | 2 | |||
Acquisition of subsidiaries, net of cash and cash equivalents acquired | 9 | 2 | 7 | |||
Proceeds from sale of subsidiaries, net of cash and cash equivalents acquired | – | (3) | 3 | |||
Expenditure for equity-accounted investees | – | 1 | (1) | |||
Purchase of other financial assets | 1 | 2 | (1) | |||
Proceeds from other financial assets | (12) | (11) | (1) | |||
Other cash flows from investing activities | – | 1 | (1) | |||
Other cash flows from financing activities | (2) | (1) | (1) | |||
Free cash flow | 198 | 209 | (11) |